Latest stories on SABS
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
GlobeNewswire52 · neutralproduct/pr
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
Business Insider53 · neutralproduct/pr
SAB Biotherapeutics granted Fast Track designation for SAB-142
The Fly64 · neutralproduct/pr
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
Business Insider68 · bullishproduct/pr
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
GlobeNewswire74 · bullishproduct/pr
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
GlobeNewswire63 · neutralproduct/pr
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
Business Insider63 · neutralproduct/pr
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
Business Insider63 · neutralproduct/pr
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
GlobeNewswire63 · neutralproduct/pr
SAB Biotherapeutics, Inc. (SABS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha55 · neutralgeneral
SAB BIO to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
SAB BIO to Participate in Upcoming Investor Conferences
GlobeNewswire55 · neutralgeneral
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 Assessment
Yahoo Finance63 · neutralproduct/pr
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
TipRanks63 · neutralproduct/pr
SAB Biotherapeutics, Inc. (SABSW) files 8-K
SEC 8-K50 · neutralgeneral
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Business Insider59 · neutralgeneral
Why Is H.C. Wainwright Bullish On SAB Biotherapeutics (SABS) With $10 Price Target?
Yahoo Top63 · neutralanalyst
Barclays Assigns Overweight Rating to SAB Biotherapeutics Inc. (SABS)
Yahoo Finance61 · neutralanalyst
SAB Biotherapeutics, Inc. (SABS) Presents at FOCIS 2026 Annual Meeting - Slideshow
Seeking Alpha50 · neutralgeneral